Avita Therapeutics Inc
Suletud
3.92 -1.26
Ülevaade
Aktsiahinna muutus
24h
Min
3.88
Max
3.95
Sissetulek | 1M -11M |
|---|---|
Müük | 1.6M 19M |
Aktsiakasum | -0.48 |
Kasumimarginaal | -55.119 |
Töötajad | 226 |
EBITDA | 1.1M -8.6M |
Soovitused | Tugev "osta" hinnang |
|---|---|
12 kuu keskmine prognoos | +83.38% upside |
Järgmine tulemuste avaldamine | 6. aug 2026 |
|---|
Turukapital | -5.8M 129M |
|---|---|
Eelmine avamishind | 5.18 |
Eelmine sulgemishind | 3.92 |
Avita Therapeutics Inc Graafik
Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.
Ettevõttest Avita Therapeutics Inc
AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.
